Vanda Pharmaceuticals
VNDA
#7903
Rank
C$0.49 B
Marketcap
C$8.23
Share price
0.17%
Change (1 day)
32.38%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.21 Billion. In 2024 the company made an earning of -C$56.91 Million a decrease over its 2023 earnings that were of -C$19.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion198.25%
2024 -C$56.91 Million191.43%
2023 -C$19.53 Million-320.45%
2022 C$8.85 M-84.99%
2021 C$59.01 M54.8%
2020 C$38.12 M19.42%
2019 C$31.92 M4.93%
2018 C$30.42 M-228.6%
2017 -C$23.66 Million-8.98%
2016 -C$26 Million-53.79%
2015 -C$56.25 Million-30.18%
2014 -C$80.56 Million173.08%
2013 -C$29.5 Million-25.33%
2012 -C$39.51 Million163.61%
2011 -C$14.99 Million-221.15%
2010 C$12.36 M-124.53%
2009 -C$50.44 Million-29.44%
2008 -C$71.48 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$91.97 Million170.55%
2005 -C$34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.36 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.09 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.82 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.56 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.40 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.43 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$3.93 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA